LYMPHACT

Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments. Their products and technologies are designed to harness the power of the immune system, the target-specific cellular mechanism which evolved in vertebrates during the last 450 million years, towards a permanent elimination of pathogens. After 5 years of pioneering research and development in this field, they created a new technology platform which can generate autologous and allogeneic cellular immune therapies for clinical applications: DOT-Cells®.